PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19

ABSTRACT Coronavirus Disease 2019 (COVID-19) is the disease which was declared a global pandemic by the World Health Organization (WHO) in early 2020. Up to this date, the diagnosis of COVID-19 has been relying on the gold standard, namely RT-PCR which requires a fee relatively expensive and time co...

Full description

Saved in:
Bibliographic Details
Main Authors: Muliawan, Raden Muhammad Bagus, Rosita, Linda
Format: UMS Journal (OJS)
Language:eng
Published: Universitas Muhammadiyah Surakarta 2023
Subjects:
Online Access:https://journals2.ums.ac.id/index.php/biomedika/article/view/3312
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1805340819574489088
author Muliawan, Raden Muhammad Bagus
Rosita, Linda
author_facet Muliawan, Raden Muhammad Bagus
Rosita, Linda
author_sort Muliawan, Raden Muhammad Bagus
collection OJS
description ABSTRACT Coronavirus Disease 2019 (COVID-19) is the disease which was declared a global pandemic by the World Health Organization (WHO) in early 2020. Up to this date, the diagnosis of COVID-19 has been relying on the gold standard, namely RT-PCR which requires a fee relatively expensive and time consuming. Platelet lymphocyte ratio (PLR) is thought be a hematological biomarker that help health workers in determining the diagnosis of patients suffering from COVID-19. The purpose of this study is to determine the performance of PLR as a method for diagnosing COVID-19. This research is a quantitative study with a cross-sectional study approach. This study used secondary data using a sampling method in the form of consecutive sampling on medical record data of suspected COVID-19 patients stored at Soedirman General Hospital, Kebumen. Data were then analyzed using univariate and diagnostic test. There were 154 patient medical record data that met the inclusion and exclusion criteria. Diagnostic test analysis using the ROC curve and 2x2 table obtained an optimal PLR cut-off of 142.5 with a sensitivity of 62%, a specificity of 58%, a positive predictive value of 92%, a negative predictive value of 16%, likelihood ratio + 1.50, likelihood ratio - 0.64, and area under curve 0.583. The conclusion of this study was PLR cannot be used as a diagnostic for COVID-19     ABSTRAK Coronavirus Disease 2019 (COVID-19) adalah penyakit yang dideklarasikan sebagai pandemi global oleh World Health Organization (WHO) pada awal tahun 2020. Diagnosis COVID-19 hingga saat ini bertumpu pada gold standart yakni RT-PCR yang membutuhkan biaya relatif mahal dan waktu yang cukup lama. Platelet lymphocyte ratio (PLR) diduga dapat sebagai biomarker hematologi yang dapat membantu tenaga kesehatan dalam penentuan diagnosis pasien menderita COVID-19. Penelitian ini bertujuan untuk mengetahui performa PLR sebagai metode diagnosis COVID-19. Penelitian ini merupakan studi kuantitatif dengan pendekatan cross-sectional. Penelitian ini menggunakan data sekunder dengan metode consecutive sampling dari rekam medis pasien suspek COVID-19 di RS X Kebumen. Data kemudian dianalisis univariat dan dilakukan uji diagnostik. Didapatkan sebanyak 154 data pasien yang memenuhi kriteria inklusi dan eksklusi. Analisis uji diagnostik menggunakan kurva ROC dan tabel 2x2 didapatkan cut-off optimal PLR sebesar 142,5 dengan sensitivitas 62%, spesifisitas 58%, positive predictive value (PPV) 92%, negative predictive value (NPV) 16%, likelihood ratio + 1.50, likelihood ratio - 0.64, dan area under curve 0,583. Kesimpulan penelitian ini bahwa PLR belum bisa digunakan sebagai diagnostik COVID-19
format UMS Journal (OJS)
id oai:ojs2.journals2.ums.ac.id:article-3312
institution Universitas Muhammadiyah Surakarta
language eng
publishDate 2023
publisher Universitas Muhammadiyah Surakarta
record_format ojs
spelling oai:ojs2.journals2.ums.ac.id:article-3312 PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19 Muliawan, Raden Muhammad Bagus Rosita, Linda Covid-19 Diagnostic Test PLR Uji Diagnostik ABSTRACT Coronavirus Disease 2019 (COVID-19) is the disease which was declared a global pandemic by the World Health Organization (WHO) in early 2020. Up to this date, the diagnosis of COVID-19 has been relying on the gold standard, namely RT-PCR which requires a fee relatively expensive and time consuming. Platelet lymphocyte ratio (PLR) is thought be a hematological biomarker that help health workers in determining the diagnosis of patients suffering from COVID-19. The purpose of this study is to determine the performance of PLR as a method for diagnosing COVID-19. This research is a quantitative study with a cross-sectional study approach. This study used secondary data using a sampling method in the form of consecutive sampling on medical record data of suspected COVID-19 patients stored at Soedirman General Hospital, Kebumen. Data were then analyzed using univariate and diagnostic test. There were 154 patient medical record data that met the inclusion and exclusion criteria. Diagnostic test analysis using the ROC curve and 2x2 table obtained an optimal PLR cut-off of 142.5 with a sensitivity of 62%, a specificity of 58%, a positive predictive value of 92%, a negative predictive value of 16%, likelihood ratio + 1.50, likelihood ratio - 0.64, and area under curve 0.583. The conclusion of this study was PLR cannot be used as a diagnostic for COVID-19     ABSTRAK Coronavirus Disease 2019 (COVID-19) adalah penyakit yang dideklarasikan sebagai pandemi global oleh World Health Organization (WHO) pada awal tahun 2020. Diagnosis COVID-19 hingga saat ini bertumpu pada gold standart yakni RT-PCR yang membutuhkan biaya relatif mahal dan waktu yang cukup lama. Platelet lymphocyte ratio (PLR) diduga dapat sebagai biomarker hematologi yang dapat membantu tenaga kesehatan dalam penentuan diagnosis pasien menderita COVID-19. Penelitian ini bertujuan untuk mengetahui performa PLR sebagai metode diagnosis COVID-19. Penelitian ini merupakan studi kuantitatif dengan pendekatan cross-sectional. Penelitian ini menggunakan data sekunder dengan metode consecutive sampling dari rekam medis pasien suspek COVID-19 di RS X Kebumen. Data kemudian dianalisis univariat dan dilakukan uji diagnostik. Didapatkan sebanyak 154 data pasien yang memenuhi kriteria inklusi dan eksklusi. Analisis uji diagnostik menggunakan kurva ROC dan tabel 2x2 didapatkan cut-off optimal PLR sebesar 142,5 dengan sensitivitas 62%, spesifisitas 58%, positive predictive value (PPV) 92%, negative predictive value (NPV) 16%, likelihood ratio + 1.50, likelihood ratio - 0.64, dan area under curve 0,583. Kesimpulan penelitian ini bahwa PLR belum bisa digunakan sebagai diagnostik COVID-19 Universitas Muhammadiyah Surakarta 2023-08-01 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article application/pdf https://journals2.ums.ac.id/index.php/biomedika/article/view/3312 10.23917/biomedika.v15i2.3312 Biomedika; Vol 15, No 2 (2023): Biomedika Agustus 2023; 156 - 165 2541-2582 2085-8345 eng https://journals2.ums.ac.id/index.php/biomedika/article/view/3312/880 Copyright (c) 2023 Biomedika https://creativecommons.org/licenses/by/4.0
spellingShingle Covid-19
Diagnostic Test
PLR
Uji Diagnostik
Muliawan, Raden Muhammad Bagus
Rosita, Linda
PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19
title PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19
title_full PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19
title_fullStr PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19
title_full_unstemmed PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19
title_short PERAN DIAGNOSTIK PLATELET LYMPHOCYTE RATIO PADA PASIEN TERKONFIRMASI POSITIF COVID-19
title_sort peran diagnostik platelet lymphocyte ratio pada pasien terkonfirmasi positif covid 19
topic Covid-19
Diagnostic Test
PLR
Uji Diagnostik
topic_facet Covid-19
Diagnostic Test
PLR
Uji Diagnostik
url https://journals2.ums.ac.id/index.php/biomedika/article/view/3312
work_keys_str_mv AT muliawanradenmuhammadbagus perandiagnostikplateletlymphocyteratiopadapasienterkonfirmasipositifcovid19
AT rositalinda perandiagnostikplateletlymphocyteratiopadapasienterkonfirmasipositifcovid19